Question · asked by 1 review
Complete cure and adverse events for terbinafine vs griseofulvin: Severe adverse events
- Population
- children with tinea capitis
- Intervention
- Complete cure and adverse events for terbinafine
- Comparison
- griseofulvin
- Outcome
- Severe adverse events
Complete cure and adverse events for terbinafine showed no clear difference in severe adverse events compared with griseofulvin (moderate certainty).
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Complete cure and adverse events for terbinafine vs griseofulvin Severe adverse events · children with tinea capitis Complete cure and adverse events for terbinafine showed no clear difference in severe adverse events compared with griseofulvin (moderate certainty). Systemic antifungal therapy for tinea capitis in children (2016) · Cochrane Headline outcomes only | RR 0.97 [0.24, 3.88] | 1 study · 1549 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.